Mitoxantrone injection USP (2014-11-21)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| A024636AC | - Recalling Firm
- Hospira Healthcare Corporation
- Suite 600 - 1111 Dr. Frederik Philips Blvd
- Saint-Laurent
- H4M 1X6
- Quebec
- CANADA
- Marketing Authorization Holder
- Hospira Healthcare Corporation
- Suite 600 - 1111 Dr. Frederik Philips Blvd
- Saint-Laurent
- H4M 1X6
- Quebec
- CANADA
| Mitoxantrone injection USP | Solution | DIN 02244614 | 2 mg/mL |
Recalled products
Mitoxantrone injection USP
Lot A024636AC did not meet the specification for the individual unknown impurity during the stability testing.